ImmunityBio, Inc.
ImmunityBio, Inc. (IBRX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · IBRX · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
9
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
ImmunityBio, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
IBRX insider buying and selling by quarter
IBRX insider selling · IBRX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · IBRX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
IBRX executive sell shares · IBRX board member insider trading · IBRX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 4, 2026 | Simon Barry J. Director | Sale | 23,033 | $165K | Form 4 |
| Mar 31, 2026 | SOON-SHIONG PATRICK See remarks · Director | Other | 4,606,596 | $25.00M⚡ | Form 4 |
| Feb 24, 2026 | Simon Barry J. Director | Sale | 75,000 | $901K | Form 4 |
| Feb 23, 2026 | Selecky Christobel Director | Option | 25,000 | $75K | Form 4 |
| Feb 23, 2026 | Selecky Christobel Director | Sale | 25,000 | $250K | Form 4 |
| Feb 22, 2026 | Sachs David C. CFO | Option | 40,650 | — | Form 4 |
| Feb 22, 2026 | Sachs David C. CFO | Other | 20,682 | $180K | Form 4 |
| Feb 22, 2026 | SOON-SHIONG PATRICK See remarks · Director | Option | 114,329 | — | Form 4 |
| Feb 22, 2026 | SOON-SHIONG PATRICK See remarks · Director | Other | 58,170 | $506K | Form 4 |
| Feb 22, 2026 | LAUER REGAN J CAO | Option | 4,065 | — | Form 4 |
| Feb 22, 2026 | LAUER REGAN J CAO | Other | 1,673 | $15K | Form 4 |
| Feb 22, 2026 | Adcock Richard CEO & President · Director | Option | 152,439 | — | Form 4 |
| Feb 22, 2026 | Adcock Richard CEO & President · Director | Other | 77,560 | $675K | Form 4 |
| Feb 22, 2026 | Simon Barry J. Director | Option | 15,243 | — | Form 4 |
| Feb 22, 2026 | Simon Barry J. Director | Other | 6,026 | $52K | Form 4 |
| Feb 20, 2026 | Simon Barry J. Director | Sale | 10,000 | $93K | Form 4 |
| Feb 23, 2026 | Simon Barry J. Director | Sale | 165,000 | $1.69M⚡ | Form 4 |
| Feb 10, 2026 | SOON-SHIONG PATRICK See remarks · Director | Option | 274,122 | — | Form 4 |
| Feb 10, 2026 | SOON-SHIONG PATRICK See remarks · Director | Other | 118,560 | $822K | Form 4 |
| Feb 10, 2026 | Sachs David C. CFO | Option | 82,236 | — | Form 4 |
| Feb 10, 2026 | Sachs David C. CFO | Other | 42,643 | $296K | Form 4 |
| Feb 10, 2026 | LAUER REGAN J CAO | Option | 5,482 | — | Form 4 |
| Feb 10, 2026 | LAUER REGAN J CAO | Other | 2,257 | $16K | Form 4 |
| Feb 10, 2026 | Adcock Richard CEO & President · Director | Option | 274,122 | — | Form 4 |
| Feb 10, 2026 | Adcock Richard CEO & President · Director | Other | 140,048 | $971K | Form 4 |
SOON-SHIONG PATRICK
See remarks · Director
Date
Mar 31
Shares
4,606,596
Price
$5.43
Value
$25.00M ⚡
SOON-SHIONG PATRICK
See remarks · Director
Date
Feb 22
Shares
114,329
Price
—
Value
—
SOON-SHIONG PATRICK
See remarks · Director
Date
Feb 22
Shares
58,170
Price
$8.70
Value
$506K
Adcock Richard
CEO & President · Director
Date
Feb 22
Shares
152,439
Price
—
Value
—
Adcock Richard
CEO & President · Director
Date
Feb 22
Shares
77,560
Price
$8.70
Value
$675K
SOON-SHIONG PATRICK
See remarks · Director
Date
Feb 10
Shares
274,122
Price
—
Value
—
SOON-SHIONG PATRICK
See remarks · Director
Date
Feb 10
Shares
118,560
Price
$6.93
Value
$822K
Adcock Richard
CEO & President · Director
Date
Feb 10
Shares
274,122
Price
—
Value
—
Adcock Richard
CEO & President · Director
Date
Feb 10
Shares
140,048
Price
$6.93
Value
$971K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About IBRX insider trading
IBRX insider trades
ImmunityBio, Inc. (IBRX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Simon Barry J. (Director), Selecky Christobel (Director), Sachs David C. (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. IBRX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For ImmunityBio, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
IBRX insider trading · 5 questionsThe insiders of ImmunityBio, Inc. (IBRX) include executives and directors such as Simon Barry J. (Director), Selecky Christobel (Director), Sachs David C. (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026